skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial Activity

Journal Article · · Journal of Medicinal Chemistry

Malaria persists as one of the most devastating global infectious diseases. The pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase (DHODH) has been identified as a new malaria drug target, and a triazolopyrimidine-based DHODH inhibitor 1 (DSM265) is in clinical development. We sought to identify compounds with higher potency against Plasmodium DHODH while showing greater selectivity toward animal DHODHs. Herein we describe a series of novel triazolopyrimidines wherein the p-SF5-aniline was replaced with substituted 1,2,3,4-tetrahydro-2-naphthyl or 2-indanyl amines. These compounds showed strong species selectivity, and several highly potent tetrahydro-2-naphthyl derivatives were identified. Compounds with halogen substitutions displayed sustained plasma levels after oral dosing in rodents leading to efficacy in the P. falciparum SCID mouse malaria model. These data suggest that tetrahydro-2-naphthyl derivatives have the potential to be efficacious for the treatment of malaria, but due to higher metabolic clearance than 1, they most likely would need to be part of a multidose regimen.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
National Inst. of Health
Grant/Contract Number:
R01AI103947; U01AI075594
OSTI ID:
1267477
Journal Information:
Journal of Medicinal Chemistry, Vol. 59, Issue 11; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 41 works
Citation information provided by
Web of Science

References (34)

Malaria journal February 2014
Malaria biology and disease pathogenesis: insights for new treatments journal February 2013
Malaria medicines: a glass half full?
  • Wells, Timothy N. C.; van Huijsduijnen, Rob Hooft; Van Voorhis, Wesley C.
  • Nature Reviews Drug Discovery, Vol. 14, Issue 6 https://doi.org/10.1038/nrd4573
journal May 2015
Designing the next generation of medicines for malaria control and eradication journal January 2013
The State of the Art in Anti-Malarial Drug Discovery and Development journal May 2011
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates journal December 2014
Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance journal December 2014
Genetic architecture of artemisinin-resistant Plasmodium falciparum journal January 2015
Antimalarial drug discovery – the path towards eradication journal July 2013
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential journal August 2011
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria journal July 2015
Plasmodium Dihydroorotate Dehydrogenase: A Promising Target for Novel Anti-Malarial Chemotherapy journal June 2010
Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitors with Potent and Selective Activity against the Malaria Parasite Plasmodium falciparum journal June 2008
Identification of a Metabolically Stable Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Antimalarial Activity in Mice journal March 2009
Structural Plasticity of Malaria Dihydroorotate Dehydrogenase Allows Selective Binding of Diverse Chemical Scaffolds journal September 2009
Fluorine Modulates Species Selectivity in the Triazolopyrimidine Class of Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors journal June 2014
Lead Optimization of Aryl and Aralkyl Amine-Based Triazolopyrimidine Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Antimalarial Activity in Mice journal June 2011
Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection journal May 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance journal October 2011
Drug-Induced Long QT Syndrome journal November 2010
Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2R null Mice Engrafted with Human Erythrocytes journal July 2009
Halogen Interactions in Protein–Ligand Complexes: Implications of Halogen Bonding for Rational Drug Design journal November 2013
Malarial Dihydroorotate Dehydrogenase journal November 2002
Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model* journal October 2010
A High-Throughput Screening Method for the Determination of Aqueous Drug Solubility Using Laser Nephelometry in Microtiter Plates journal April 2000
Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update journal April 2008
Quinolone-3-Diarylethers: A New Class of Antimalarial Drug journal March 2013
SIR 97: a new tool for crystal structure determination and refinement journal February 1999
Completion and refinement of crystal structures with SIR 92 journal June 1993
New analytical scattering-factor functions for free atoms and ions journal May 1995
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Solving structures of protein complexes by molecular replacement with Phaser journal December 2006
Coot model-building tools for molecular graphics journal November 2004
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010

Cited By (1)

A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria journal October 2016